On Nov. 26 and 27, two hospitals from Italy, one from Germany and one from Switzerland received the first phase of certification training for implanting the CardioWest™ temporary Total Artificial Heart (TAH-t) in Paris... read more
On Nov. 17, Drs. Marvin Slepian and Jack Copeland, co-founders of artificial heart manufacturer SynCardia Systems, Inc., led SynCardia’s cycling team... read more
Two months after being implanted with a Left Ventricular Assist Device (LVAD) to support his dying heart, Mike Gadiel’s heart began to fail... read more
In a period of just 13 days, a 56-year-old Gilbert, Ariz., woman has felt the beating of three different hearts – all within her own chest... read more
Sixty years ago, Willem J. Kolff, M.D., Ph.D., the world’s most accomplished and prolific creator of artificial organs, started work that led to... read more
With four months left in 2007, on Aug. 28, the German Heart Institute Berlin implanted its 10th CardioWest™ temporary Total Artificial Heart... read more
On July 17 and 18, cardiothoracic surgeon Dr. Stephen Clayson, M.D., and his heart transplant team from LDS Hospital in Utah, are in Tucson receiving the first phase of certification training to implant the CardioWest temporary Total Artificial Heart (TAH-t)... read more
Marvin J. Slepian, M.D., chairman and co-founder of SynCardia Systems, Inc., will present a prototype of a smaller TAH-t designed for use in women... read more
Bartley Griffith, M.D., and his cardiac transplant team from the University of Maryland Medical Center (UMMC) will complete phase one, of the four-part CardioWest TAH-t Certification Program on June 14 and 15... read more
SynCardia Systems, Inc., manufacturer of the world’s only FDA and CE Mark approved temporary Total Artificial Heart (TAH-t), is announcing the availability for clinical investigation of a portable driver that is designed to allow stable U.S. patients to recover at home while they wait for their donor heart for transplant... read more
SynCardia Systems, Inc., manufacturer of the world’s first and only FDA and CE Mark approved temporary Total Artificial Heart is looking to the future so this lifesaving technology can be used to save more patients... read more
A 46-year-old former fitness instructor, suffering from biventricular endstage heart failure and in irreversible cardiogenic shock, has become the first... read more
Dr. Marvin Slepian, co-founder and chairman of SynCardia Systems, Inc. will be presenting the CardioWest™ temporary Total Artificial Heart (TAH-t) at the 4th International Wine and Heart Health summit at the Silverado Resort in Napa Valley, CA on February 17th... read more
